85 year old male presented with progressive dyspnea on exertion (NYHA Class III). Past medial history was significant for MI, CAD with CABG, AF, CKD and Asthma. TTE revealed severe mitral regurgitation with preserved LV function. Coronary angiogram showed native III V CAD and patent grafts. TEE confirmed severe mitral regurgitation (Carpentier type III) with restricted motion of posterior leaflet and two jets located between A2/P2 scallops. The STS mortality risk for Surgical MVR was 17.82 % and the Logistic Euroscore mortality risk was 58.93%. Patient was determined to be at extreme risk for surgical MVR due to co-morbidities. Pt is now planned for mitral valve edge-to-edge repair with MitraClip.
ViV TAVR with 26mm Evolut FX Valve in Degenerated Surgical Valve After Valve Fracture – September 2022